Literature DB >> 20671721

Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat.

John Behbahani1, Sijo J Thandapilly, Xavier L Louis, Yingsu Huang, Zongjun Shao, Melanie A Kopilas, Peter Wojciechowski, Thomas Netticadan, Hope D Anderson.   

Abstract

BACKGROUND: Small arteries from the spontaneously hypertensive rat (SHR) exhibit abnormal stiffness and geometry. This study investigated the effects of resveratrol, a polyphenol found in foods such as red grapes, on small arteries in SHR.
METHODS: Wistar-Kyoto (WKY) rats and SHR were treated with resveratrol (2.5 mg/kg/day) for 10 weeks. Mesenteric small artery segments (third-order branches) were mounted in a pressure myograph, and vascular geometry and mechanical properties were calculated from lumen and media dimensions measured at incremental intraluminal pressures. Systolic blood pressure was measured by tail-cuff plethysmography.
RESULTS: Increased compliance and reduced wall component stiffness were observed in SHR arteries vs. WKY arteries. Though resveratrol did not prevent lowering of wall component stiffness, it did attenuate, at least in part, the increased compliance of SHR arteries. In contrast, resveratrol increased compliance and reduced wall component stiffness in WKY arteries. SHR arteries exhibited remodeling that consisted of narrowed lumens, thickened media widths, and augmented media-to-lumen ratios. Resveratrol partially attenuated the remodeling process and also abolished exaggerated ERK signaling and expression of proliferating cell nuclear antigen (a marker of proliferation) in SHR arteries. The latter effects might be related to the ability of resveratrol to alleviate oxidative stress in SHR and enhance protein kinase G (PKG) activity. Elevated blood pressure in 20-week-old SHR was unaffected by resveratrol.
CONCLUSIONS: The ability of resveratrol to limit the increase in compliance of SHR arteries is likely related to inhibitory effects on remodeling and pro-growth ERK signaling rather than blood pressure or arterial wall component stiffness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671721     DOI: 10.1038/ajh.2010.161

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  16 in total

Review 1.  Resveratrol in cardiovascular disease: what is known from current research?

Authors:  Hong Wang; Yue-Jin Yang; Hai-Yan Qian; Qian Zhang; Hui Xu; Jian-Jun Li
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 2.  Resveratrol in the prevention and treatment of coronary artery disease.

Authors:  Louis M Chu; Antonio D Lassaletta; Michael P Robich; Frank W Sellke
Journal:  Curr Atheroscler Rep       Date:  2011-12       Impact factor: 5.113

Review 3.  What is new for an old molecule? Systematic review and recommendations on the use of resveratrol.

Authors:  Ole Vang; Nihal Ahmad; Clifton A Baile; Joseph A Baur; Karen Brown; Anna Csiszar; Dipak K Das; Dominique Delmas; Carmem Gottfried; Hung-Yun Lin; Qing-Yong Ma; Partha Mukhopadhyay; Namasivayam Nalini; John M Pezzuto; Tristan Richard; Yogeshwer Shukla; Young-Joon Surh; Thomas Szekeres; Tomasz Szkudelski; Thomas Walle; Joseph M Wu
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

4.  Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats.

Authors:  Apurva A Javkhedkar; Yasmir Quiroz; Bernardo Rodriguez-Iturbe; Nosratola D Vaziri; Mustafa F Lokhandwala; Anees A Banday
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-11       Impact factor: 3.619

Review 5.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 6.  Proinflammation: the key to arterial aging.

Authors:  Mingyi Wang; Liqun Jiang; Robert E Monticone; Edward G Lakatta
Journal:  Trends Endocrinol Metab       Date:  2013-12-20       Impact factor: 12.015

7.  The protective effects of ginsenoside Rg1 against hypertension target-organ damage in spontaneously hypertensive rats.

Authors:  Hui Chen; Jun Yin; Yanpin Deng; Min Yang; Lingling Xu; Fukang Teng; Defang Li; Yufan Cheng; Sha Liu; Dong Wang; Tingting Zhang; Wanying Wu; Xuan Liu; Shuhong Guan; Baohong Jiang; Dean Guo
Journal:  BMC Complement Altern Med       Date:  2012-04-25       Impact factor: 3.659

Review 8.  Polyphenols: benefits to the cardiovascular system in health and in aging.

Authors:  Sandhya Khurana; Krishnan Venkataraman; Amanda Hollingsworth; Matthew Piche; T C Tai
Journal:  Nutrients       Date:  2013-09-26       Impact factor: 5.717

9.  Heterogeneity in arterial remodeling among sublines of spontaneously hypertensive rats.

Authors:  Erik N T P Bakker; Gergely Groma; Léon J A Spijkers; Judith de Vos; Angela van Weert; Henk van Veen; Vincent Everts; Silvia M Arribas; Ed VanBavel
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

10.  Aortic Remodelling Is Improved by 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside Involving the Smad3 Pathway in Spontaneously Hypertensive Rats.

Authors:  Ju Duan; Xin Han; Shuang Ling; Woting Gan; Li Sun; Rong-Zhen Ni; Jin-Wen Xu
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.